Comparative study of CNR1 and CNR2 cannabinoid receptors expression levels in COVID-19 patients with and without diabetes mellitus: Recommendations for future research targets
Fatemeh Aghamahdi(Jahrom University of Medical Sciences), Sayed‐Hamidreza Mozhgani(Jahrom University of Medical Sciences), Zeinab Siami(Jahrom University of Medical Sciences), Sayeh Rostami(Jahrom University of Medical Sciences), Gholamreza Azizi(Jefferson Hospital for Neuroscience), Arman Shafiee(Jahrom University of Medical Sciences), Mahmood Bakhtiyari(Jahrom University of Medical Sciences), Mahshid Safavi(Jahrom University of Medical Sciences), Somayeh Yaslianifard(Jahrom University of Medical Sciences), Zakiye Mokhames(Jahrom University of Medical Sciences)
Cited by 7
Related Papers
Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach
|International Immunopharmacology|2022|384
Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment
|Frontiers in Immunology|2022|363
Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management
|Scandinavian Journal of Immunology|2020|339
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312
Primary immunodeficiency and autoimmunity: A comprehensive review
|Journal of Autoimmunity|2019|239